Antioxidative and chemopreventive properties of Vernonia amygdalina and Garcinia biflavonoid

International Journal of Environmental Research and Public Health

Volumn 8, Issue 6, 2011, Pages 2533-2555

  Farombi, Ebenezer O ^a   Owoeye, Olatunde ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Antioxidants; Chemoprevention; Epivernodalol; Garcinia kola; Kolaviron; Vernonia amygdalina

Indexed keywords

ALDEHYDE REDUCTASE; AROMATASE; BIFLAVONOID; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; DELTA TOCOTRIENOL; DOXORUBICIN; FLAVONOID; GARCINAL; GARCINIA KOLA EXTRACT; GARCINOIC ACID; HEAT SHOCK PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; KOLAVIRON; LUTEOLIN; LUTEOLIN 7 GLUCOSIDE; LUTEOLIN 7 O BETA GLUCURONOSIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER; TOCOPHEROL DERIVATIVE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VERNODALIN; VERNOMYGDIN; VERNONIA AMYGDALINA EXTRACT;

ANOREXIA; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CHEMOPROPHYLAXIS; CYCLOOXYGENASE 2 GENE; DIABETES MELLITUS; DIARRHEA; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG DNA BINDING; DRUG EFFECT; DRUG ISOLATION; DRUG MECHANISM; DRUG METABOLISM; DRUG SCREENING; DRUG STRUCTURE; DYSENTERY; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; GENE; GENOTOXICITY; HUMAN; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; LARYNGITIS; LC 50; LIPID OXIDATION; LIVER DISEASE; LIVER INJURY; LIVER PROTECTION; LIVER TOXICITY; NAUSEA; NONHUMAN; OXIDATIVE STRESS; PHYTOCHEMISTRY; PROTEIN SYNTHESIS INHIBITION; REVIEW; SLEEP DISORDER; TRADITIONAL MEDICINE; VOMITING;

ASTERACEAE; BACTERIA (MICROORGANISMS); CLUSIACEAE; GARCINIA; GARCINIA KOLA; VERNONIA AMYGDALINA;

EID: 79959849020     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph8062533     Document Type: Review

References (96)

1. Aruoma, O.I.; Sun, B.; Fuji, H.; Neergheen, V.S.; Bahorun, T.; Kang, K.S.; Sung, M.K. Low molecular proanthocyamidin dietary biofactor oligonol: Its modulation of oxidative stress, bioefficacy, neuroprotection, food application and chemoprevention potentials. Biofactors 2006, 27, 245-265.
2. Seef, L.B.; Lindsay, K.L.; Bacon, B.R.; Kresina, T.F.; Hoofnagle, J.H. Complementary and alternative medicine in chronic liver disease. Hepatology 2001, 34, 595-603.
3. Winslow, L.C.; Krol, D.J. Herbs as medicines. Arch. Intern. Med. 1998, 1258, 2192-2199.
4. Kupchan, S.M.; Hemmnigway, R.J.; Karim, A.; Werner, D. Tumor inhibitors. XLVII Vernodalin and Vernomygdin. Two new cytotoxic sesquiterpene lactones from Vernonia amygdalina Del. J. Org. Chem. 1969, 34, 3908-3911.
5. Moundipa, F.P.; Kamini, G.; Melanie, F.; Bilong, F.C.; Bruchhaus, I. In vitro amoebic activity of some medicinal plants of the Bamun region (Cameroon). Afr. J. Tad. Cam. 2000, 62, 113-121.
6. Akah, P.A.; Ekekwe, R.K. Ethnopharmacology of some of the asteraceae family used in the Nigerian traditional medicine. Fitoterapia 1995, 66, 352-355.
7. Akinpelu, D.A. Antimicrobial activity of Vernonia amygdalina leaves. Fitoterapia 1999, 70, 232-234.
8. Hladik, C.; Krief, S.; Haxaire, C. Ethnomedicinal and bioactive properties of plants ingested by wild chimpanzees in Uganda. J. Ethnopharmacol. 2005, 101, 1-5.
9. Muraina, I.A.; Adaudi, A.O.; Mamman, M.; Kazeem, H.M.; Picard, J.; McGaw, L.J.; Eloff, J.N. Antimycoplasmal activity of some plant species from northern Nigeria compared to the currently used therapeutic agent. Pharm. Biol. 2010, 48, 1103-1107.
10. Cimanga, R.K.; Tona, L.; Mesia, K.; Musuamba, C.T.; De Bruyne, T.; Apers, S.; Hernan, N.; Miert, V.S.; Pieters, L.; Totte, J.; Vlietink, A.J. In vitro antiplasmodia acivity of extravts and fractions of seven medicinal plants used in the democratic republic of Congo. J. Ethnopharmacol. 2004, 93, 27-32.
11. Izevbigie, E.B. Discovery of water-soluble anticancer Agents (Edotides) from a vegetable found in Benin City, Nigeria. Exp. Biol. Med. 2003, 228, 293-298.
12. Hutchinson, J.; Dalziel, J.M. Flora of West Tropica Africa, 2nd ed.; Royal Botanic Garden, Kew: London, UK, 1956; p. 295.
13. Iwu, M.M. Traditional Igbo Medicine; Institute of African studies, University of Nigeria: Nsukka, Nigeria, 1982; pp. 104-110.
14. Igile, G.O.; Oleszek, W.; Burda, S.; Jurzysta, M. Nutritional assessment of Vernonia amygdalina leaves in growing mice. J. Agr. Food Chem. 1995, 43, 2162-2166.
15. Ojiako, O.A.; Nwajo, H.U. Is Vernonia amygdalina hepatotoxic or hepatoprotective? Response from biochemical and toxicity studies in rats. Afr. J. Biotechnol. 2005, 5, 1648-1651.
16. Erasto, G.; Grierson, D.S.; Afolayan, A.J. Bioactive sesquiterpene from leaves of Vernonia amygdalina. J. Ethnopharmacol. 2006, 106, 117-129.
17. Owoeye, O. Anticancer Activity of Vernonia amygdalina Del. Leaf Extract, its Antioxidant and Radioprotective Properties in the Brain of Rats; Ph. D Thesis; Department of Veterinary Medicine, University of Ibadan: Ibadan, Nigeria, 2010.
18. Bonsi, M.L.K.; Osuji, P.O.; Tuah, A.K.; Umunna, N.N. Vernonia amygdalina as a supplement to teff straw (Eragrosis tef.) fed to Ethiopian Menz sheep. Agroforest. Syst. 1995, 31, 229-241.
19. Huffman, M.A.; Seifu, M. Observations on the illness and consumption of a possibly medicinal plant, Vernonia amygdalina (Del.), by a wild chimpanzee in the Mahale Mountains National Park, Tanzania. Primates 1989, 30, 51-63.
20. Huffman, M.A. Self-medicative behavior in the African great apes: An evolutionary perspective into the origins of human traditional medicine. BioScience 2001, 51, 651-661.
21. Huffman, M.A. Animal self-medication and ethno-medicine: Exploration and exploitation of the medicinal properties of plants. Proc. Nutr. Soc. 2003, 62, 371-381.
22. Argheore, E.M.; Makkar, H.P.S.; Becker, K. Feed value of some browse plants from the central zone of Delta State Nigeria. Trop. Sci. 1998, 38, 97-104.
23. Ganjian, I.; Kubo, I.; Fludzinski, P. Insect antifeedant elemanolide lactones from Vernonia amygdalina. Phytochemistry 1983, 22, 2525-2526.
24. Taiwo, O.; Xu, H.-X.; Lee, S.F. Antibacteria activities of extracts from Nigerian chewing sticks. Phytother. Res. 1999, 13, 675-679.
25. Abosi, A.O.; Raseroka, B.H. In vivo antimalarial activity of Vernonia amygdalina. Br. J. Biomed. Sci. 2003, 60, 89-91.
26. Kambizi, L.; Afolayan, A.J. An ethnobotanical study of plants used for the treatment of sexually transmitted diseases (njovhera) in Guruve District, Zimbabwe. J. Ethnopharmacol. 2001, 77, 5-9.
27. Alawa, C.B.I.; Adamu, A.M.; Gefu, J.O.; Ajanusi, O.J.; Abdu, P.A.; Chiezey, N.P.; Alawa, J.N.; Bowan, D.D. In vitro screening of two Nigerian medicinal plants (Vernonia amygdalina and Annona sengalensis) for anthelmintic activity. Vet. Parasitol. 2003, 113, 78-81.
28. Izevbigie, E.B.; Bryant, J.L.; Walker, A. A novel natural inhibitor of extracellular signal-regulated kinases and human breast cancer cell growth. Exp. Biol. Med. 2004, 229, 163-169.
29. Awe, S.O.; Makinde, J.M.; Olaide, O.A. Cathartic effect of the leaf extract of Vernonia amygdalina. Fitoterapia 1999, 70, 161-165.
30. Alabi, D.A.; Onibudo, M.Z.; Amusa, N.A. Chemicals and nutritional composition of four botanicals with fungitoxic properties. World J. Agr. Sci. 2005, 1, 84-88.
31. Regassa, A. The use of herbal preparation for tick control in Western Ethiopia. J. S. Afr. Vet. Assoc. 2000, 71, 240-243.
32. Amira, C.A.; Okubadejo, N.U. Frequency of complementary and alternative medicine utilization in hypertensive patients attending an urban tertiary care centres in Nigeria. BMC Compl. Alternative Med. 2007, 7, 30-48.
33. Igile, G.O.; Oleszek, W.; Jurzysta, M.; Burda, S.; Fafunso, M.; Fasanmade, A.A. Flavonoids from Vernonia amygdalina and their antioxidant activities. J. Agric. Food Chem. 1994, 42, 2445-2448.
34. Jisaka, M.; Ohigashi, H.; Takagaki, T.; Nozaki, H.; Tada, T.; Hirota, M.; Irie, R.; Huffman, M.A.; Nishida, T.; Kaji, M.; Koshimizu, K. Bitter steroids glucosides, vernoniosides A1, A2, and A3 and related B1 from a possible medicinal plant, Vernonia amygdalina used by wild chimpanzees. Tetrahedron 1992, 48, 625-632.
35. Jisaka, M.; Ohigashi, H.; Takegawa K.; Hirota, M.; Irie, R.; Huffman, M.A.; Koshimizu, K. Steroid glucosides from Vernonia amygdalina, a possible chimpanzee plant. Phytochemistry 1993, 34, 409-413.
36. Ohigashi, H.; Jisaka, M.; Takagaki, T.; Nozaki, H.; Tada, T.; Huffman, M.A.; Nishida, T.; Kaji, M.; Koshimizu, K. Bitter principle and a related steroid glucoside from Vernonia amygdalina, a possible medicinal plant for wild chimpanzees. Agr. Biol. Chem. 1991, 55, 1201-1203.
37. Owoeye, O.; Yousuf, S.; Akhtar, M.N.; Qamar, K.; Dar, A.; Farombi, E.O.; Onwuka, S.K.; Choudhary, M.I. Another Anticancer Elemanolide from Vernonia amygdalina Del. Int. J. Biol. Chem. Sci. 2010, 4, 226-234.
38. Koul, J.L.; Koul, S.; Singh, C.; Taneja, S.C.; Shanmugavel, M.; Kampasi, H.; Saxena, A.K.; Qazi, G.N. In vitro Cytotoxic Elemanolides from Vernonia lasiopus. Plant. Med. 2003, 69, 164-166.
39. Singha, S.C. Medicinal Plants of Nigeria; Nigerian National Press: Lagos, Nigeria, 1965.
40. Dalziel, J.M. The Useful Plants of West Tropical Africa; Crown Overseas Agents for the Colonies: London, UK, 1937; p. 65.
41. Getahun, A. Some Common Medicinal and Poisonous Plants Used in Ethiopian Folk Medicine; Faculty of Science, Addis Ababa University: Addis Ababa, Ethiopia, 1976; p. 63.
42. Oliver, B. Medicinal Plants in Nigeria; Nigerian college of Arts, Science and Technology: Zaria, Nigeria, 1960.
43. Masaba, S.C. The antimalaria activity of Vernonia amygdalina Del (Compositae). Trans. R. Soc. Trop. Med. Hyg. 2000, 94, 694-695.
44. Iwalewa, E.O.; Adewunmi, C.O.; Omisore, N.O.A.; Adebanji, O.A.; Azike, C.K.; Adigun, A.O.; Adesina, O.A.; Olowoyo, O.G. Pro- and anti-oxidant effects and cytoprotective potentials of nine edible vegetables in South West Nigeria. J. Med. Foods 2005, 8, 539-544.
45. Iwalokun, B.A.; Efedede, B.U.; Alabi-Sofunde, J.A.; Oduala, T.; Magbagbeola, O.A.; Akinwande, A.I. Hepatoprotective and antioxidant activities of Vernonia amygdalina on acetaminophen-induced hepatic damage in mice. J. Med. Food. 2006, 9, 524-530.
46. Adesanoye, O.A.; Farombi, E.O. Hepatoprotective effects of Vernonia amygdalina (astereaceae) in rats treated with carbon tetrachloride. Exp. Toxicol. Pathol. 2010, 62, 197-206.
47. Cook, N.C.; Samman, S. Flavonoids-Chemistry, metabolism, cardioprotective effects and dietary sources. J. Nutr. Biochem. 1996, 7, 66-76.
48. Markham, K.R.; Bloor, S.J. Analysis and identification of flavonoids in practice. In Flavonoids in Health and Disease; Rice-Evans, C.A., Lester, P., Eds.; Marcel Dekker Inc.: New York, NY, USA, 1998; pp. 1-32.
49. Farombi, E.O.; Akanni, O.O.; Emerole, G.O. Antioxidative and scavenging activities of kolaviron in vitro. Pharm. Biol. 2002, 40, 107-116.
50. Mathew, J.; Latha, P.G.; George, V. Antioxidant flavonoids from Vitex peduncularis. J. Trop. Med. Plants 2004, 5, 217-221.
51. Schuldt, E.Z.; Favias, M.R.; Ribeiro-do-Valle, R.M.; Ckless, K. Comparative study of radical scavenger activities of crude extract and fractions of Cuphea carthagenesis leaves. Phytomedicine 2004, 11, 523-529.
52. Prabhakar, K.R.; Veeresh, V.P.; Vipan, K.; Sudheer, M.; Priyadarsini, K.I.; Satish, R.B.S.S.; Unnikrishnan, M.K. Bioactivity guided fractionation of Coronopus didymus: A free radical scavenging perspective. Phytomedicine 2006, 13, 591-595.
53. Youdim, K.A.; Dobbie, M.S.; Kuhnle, G.; Proteggente, A.R.; Abbott, N.J.; Rice-Evans, C. Interaction between flavonoids and the blood brain barrier: In vitro studies. Neurochemistry 2003, 85, 180-192.
54. Owoeye, O.; Farombi, E.O.; Onwuka, S.K. Gross morphometric reduction of rats cerebellum by gamma irradiation was mitigated by pretreatment with Vernonia amygdalina leaf extract. Rom. J. Morphol. Embryol. 2011 (in press).
55. Yedjou, C.; Izevbigie, E.; Tchounwou, P. Preclinical assessment of Vernonia amygdalina leaf extracts as DNA damaging anti-cancer agent in the management of breast cancer. IJERPH 2008, 5, 337-341.
56. Howard, C.B.; Stevens, J.; Izevbigie, E.B.; Walker, A.; McDaniel, O. Time and dose-dependent modulation of phase 1 and phase 2 gene expression in response to treatment of MCF-7 cells with a natural anti-cancer agent. Cell Mol. Biol. (Noisy-le-grand) 2003, 49, 1057-1065.
57. Rodriguez, E.; Towers, G.H.N.; Mitchell, J.C. Biological activities of sesquiterpene lactones. Phytochemistry 1976, 15, 1573-1580.
58. Sweeney, C.J.; Mehrotra, S.; Sadaria, M.R.; Kumar, S.; Shortle, N.H.; Roman, Y.; Sheridan, C.; Campbell, R.A.; Murray, D.J.; Badve, S.; Nakshatri H. The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol. Cancer Ther. 2005, 4, 1004-1012.
59. Song, Y.J.; Lee, D.Y.; Kim, S.N.; Lee, K.R.; Lee, H.W.; Han, J.W.; Kang, D.W.; Lee, H.Y.; Kim, Y.K. Apoptotic potential of sesquiterpene lactone ergolide through the inhibition of NF-κB signaling pathway. J. Pharmacol. 2005, 57, 1591-1597.
60. Colditz, G.A.; Hankinson, S.E.; Hunter, D.J.; Willett, W.C.; Manson, J.E.; Sampler, M.J.; Henneckens, C; Rosner, B.; Spiezer, F.E. The use of estrogen and progestin and the risk of cancer in postmenopausal women. NEJM 2006, 332, 1589-1595.
61. Blanco, J.G.; Gil, R.R.; Bocco, J.L.; Meragelman, T.L.; Genti-Raimondi, S.; Flury, A. Aromatase inhibition by an 11,13-Dihydroderivative of a sesquiterpene lactone. J. Pharmacol. Expt. Therap. 2001, 297, 1099-1105.
62. Ayensu, E.S. Medicinal Plants of West Africa; Reference publication Inc.: Algonac, MI, USA, 1978; pp. 162-168.
63. Braide, V.B. Antihepatotoxic biochemical effects of kolaviron, a biflavonoid of Garcinia kola seeds. Phytother. Res. 1991, 5, 35-37.
64. Iwu, M.M.; Igboko, O.A.; Okunji, CO.; Tempesta, MS. Antidiabetic and aldose reductase activities of biflavanones of Garcinia kola. J. Pharm. Pharmacol. 1990, 42, 290-292.
65. Crabbe, M.J.; Goode, D. Aldose reductase: A window to the treatment of diabetic complications? Prog. Retin. Eye Res. 1998, 17, 313-323.
66. Kinoshita, J.H.; Fukushi, S.; Kador, P.; Merola, L.O. Aldose reductase in diabetic complications of the eye. Metabolism 1979, 28, 462-469.
67. Iwu, M. Biflavanones of garcinia: Pharmacological and biological activities. In Plant Flavonoids and Medicine: Biochemical, Pharmacological and Structure Activity Relationships; Cody, V., Middleton, E., Eds.; Alan R. Liss Inc.: New York, NY, USA, 1986; pp. 485-488.
68. Farombi, E.O.; Tahnteng, J.G.; Agboola, O.; Nwankwo, J.O.; Emerole, G.O. Chemoprevention of 2-acetyl aminofluorene-induced hepatotoxicity and lipid peroxidation in rats by kolaviron-A Garcinia kola seed extract. Food Chem. Toxicol. 2000, 38, 535-541.
69. Farombi, E.O. Mechanisms for the hepatoprotective action of kolaviron: Studies on hepatic enzymes, microsomal lipids and lipid peroxidation in carbon tetrachloride-treated rats. Pharmacol. Res. 2000, 42, 75-80.
70. Farombi, E.O.; Adepoju, B.F.; Ola-Davies, O.E.; Emerole, G.O. Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by Kolaviron, a natural biflavonoid of Garcinia kola seeds. Eur. J. Canc. Prev. 2005, 14, 207-214.
71. Farombi, E.O.; Shrotriya, S.; Surh, Y.J. Kolaviron inhibits Dimethyl Nitrosamine-induced hepatotoxicity by suppressing COX-2 and iNOS expression: NF-kB and AP-1 as potential molecular targets. Life Sci. 2009, 84, 149-155.
72. Aplin, R.T.; Blasdale, J.K.C.; Halsall, T.G; Hornby, G.M.J. The isolation of cycloartenol and 24-methylenecycloartenol from false kola nuts (Garcinia kola Heckel). J. Chem. Soc. 1967, C, 246-248.
73. Cotterhill, P.J.; Scheinmann, F.; Stenhouse, T.A. Extractives from Guttiferae: Kolaflavanone, a new biflavanone from the nuts of Garcinia kola. J. Chem. Soc. 1978, Perkin I, 532-538.
74. Hussain, R.A.; Owegby, A.G.; Parimoo, A.G.; Waterman, P.G. Kolanone, a novel polyisoprenylated benzophenone with antimicrobial properties from the fruit of Garcinia kola. Plant. Med. 1982, 44, 78-81.
75. Iwu, M.M. Antihepatotoxic constituents of Garcinia kola seeds. Experientia 1985, 41, 699-700.
76. Terahima, K.; Takaya, Y.; Niwa, M. Powerful antioxidative agents based on Garcinoic acid from Garcinia kola. Biorg. Med. Chem. 2002, 10, 1619-1625.
77. Aruoma, O.I. Free radicals and international nutrition. Asia Pacific J. Clin. Nutr. 1999, 8, 53-63.
78. Farombi, E.O.; Hansen, M.; Ravn-Haren, G.; Moller, P.; Dragsted, L.O. Commonly consumed and naturally occurring dietary substances affect biomarkers of oxidative stress and DNA damage in healthy rats. Food Chem. Toxicol. 2004, 42, 1315-1322.
79. Farombi, E.O.; Moller, P.; Dragsted, L.O. Ex-vivo and in vitro protective effects of kolaviron against oxygen-derived radical-induced DNA damage and oxidative stress in human lymphocytes and rat liver cells. Cell Biol. Toxicol. 2004, 20, 71-82.
80. Nwankwo, J.O.; Tanhnteng, J.G.; Emerole, G.O. Inhibition of aflatoxin B1 genotoxicity in human liver-derived HepG2 cells by kolaviron biflavonoids and molecular mechanisms of action. Eur. J. Canc. Prev. 2000, 9, 351-361.
81. Eddy, E.P.; Howard, P.C.; McCoy, G.D.; Rosenkranz, H.S. Mutagenicity, unscheduled DNA sysnthesis, and metabolism of 1-nitropyrene in the human hepatoma cell line HepG2. Canc. Res. 1987, 47, 3163-3168.
82. Farombi, E.O.; Nwaokeafor, I.A. Anti-oxidant mechanisms of action of kolaviron: Studies on serum lipoprotein oxidation, metal chelation and oxidative microsomal membrane damage in rats. Clin. Exp. Pharmacol. Phys. 2005, 32, 667-674.
83. McKelvey-Martin, V.J.; Green, M.H.L.; Scmezer, P.; Pool-Zobel, B.L.; DeMeo, M.P. The single cell gel electrophoresis assay (comet assay): A European review. Mutat. Res. 1993, 288, 47-63.
84. Eaton, D.L.; Gallagher, E.P. Mechanisms of aflatoxin carcinogenesis. Ann. Rev. Pharmacol. Toxicol. 1994, 34, 135-172.
85. IARC. Evaluation of carcinogenic risks to human. Some naturally occurring substances: Food items and constituents, heterocyclic aromatic amines and mycotoxins. IARC Monographs 1993, 56, 362-370.
86. Wang, J.S.; Shen, X.; He, X.; Zhu, Y.-R.; Zhang, B.-C.; Wang, J.-B.; Quian, G.-S.; Kuang, S.-Y.; Zarba, A.; Egner, P.A.; Jacobson, L.P.; Munoz, A.; Helzlsouer, K.J.; Groopman, J.D.; Kensler, T.W. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, Peoples Republic of China. J. Natl. Canc. Inst. 1998, 91, 347-354.
87. Dierickx, P.J. The influence of picolines on glutathione transferase activity and subunit composition in human liver derived HepG2 cells. Biochm. Pharamcol. 1994, 48, 1976-1978.
88. Kim, S.O.; Kundu, J.K.; Shin, Y.K.; Park, J.H.; Cho, M.H.; Kim, T.Y.; Surh, Y.J. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene 2005, 24, 2558-2567.
89. Chung, W.Y.; Park, J.H.; Kim, M.J.; Kim, H.O.; Hwang, J.K.; Lee, S.K.; Park, K.K. Xanthorrhizol inhibits 12-O-tetradecanoylphorbol-13-acetate-induced acute inflammation and two-stage mouse skin carcinogenesis by blocking the expression of ornithine decarboxylase, cyclooxygenase-2 and inducible nitric oxide synthase through mitogen-activated protein kinases and/or the nuclear factor-kappa B. Carcinogenesis 2007, 28, 1224-1231.
90. Aggarwal, B.B.; Shishoda, S. Suppression of the nuclear factor (B activation pathway by spice-derived phytochemicals: Reasoning for the seasoning. Ann. NY Acad. Sci. 2004, 1030, 434-441.
91. Neergheen, V.S.; Bahorun, T.; Taylor, E.W.; Jen, L.S.; Aruoma, O.I. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention. Toxicology 2010, 278, 229-241.
92. Nanji, A.A.; Jokelainen, K.; Tipoe, G.L.; Rahemtulla, A.; Thomas, P.; Dannenberg, A.J. Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol. 2003, 284, G321-G327.
93. Fogh, J.; Trempe, X. Human Tumor Cells in Vitro; Fogh, J., Ed.; Plenum Press: New York, NY, USA, 1975; pp. 115-159.
94. Farombi, E.O. Kolaviron, a biflavonoid complex from the seed of Garcinia kola modulates cell growth in human HT29 colon adenocarcinoma cells and LT97 colon adenoma cells. Unpublished data, 2005.
95. Veeriah, S.; Hofmann, T.; Glei, M.; Dietrich, H.; Will, F.; Schreier, P.; Knaup, B.; Pool-Zobel, B.L. Apple polyphenols and products formed in the gut differently inhibit survival of human cell lines derived from colon adenoma (LT97) and carcinoma (HT29) J. Agr. Food Chem. 2007, 55, 2892-2900.
96. Farombi, E.O. Biochemical and molecular mechanisms of hepatoprotection by kolaviron, a natural antioxidant biflavonoid from Garcinia kola seed. In Nutritional Antioxidants in Cancer and Degenerative Diseases; Farombi, E.O., Ed.; Transworld Research: Kerala, India, 2009; pp.153-166.